Cargando…
Retrospective hepatitis C seroprevalence screening in the antenatal setting—should we be screening antenatal women?
OBJECTIVES: An unlinked anonymous seroprevalence study was conducted to estimate the prevalence of hepatitis C virus (HCV) infection in samples derived from antenatal clinic attendees at 2 East London Hospitals. An unexpectedly high HCV seroprevalence of 2.6% (1.2% viraemic) had been revealed during...
Autores principales: | Orkin, Chloe, Jeffery-Smith, Anna, Foster, Graham R, Tong, C Y William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885317/ https://www.ncbi.nlm.nih.gov/pubmed/27231001 http://dx.doi.org/10.1136/bmjopen-2015-010661 |
Ejemplares similares
-
Modelling the effect of the introduction of antenatal screening for group B Streptococcus (GBS) carriage in the UK
por: Bevan, David, et al.
Publicado: (2019) -
Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population
por: Flatt, Andrew, et al.
Publicado: (2013) -
High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda
por: Bayo, Pontius, et al.
Publicado: (2014) -
Non‐targeted hepatitis C virus screening in acute care healthcare settings in the Southern Appalachian region
por: Chastain, Cody A., et al.
Publicado: (2022) -
Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey
por: McQuaid, Fiona, et al.
Publicado: (2016)